From: In vitromodel for the analysis of synovial fibroblast-mediated degradation of intact cartilage
Patients (total) | Gender (male/female) | Age (years) | Disease duration (years) | RF (titre) | ESR (mm/hour) | CRP (mg/l) | Number of ARA criteria | Concomitant medication |
---|---|---|---|---|---|---|---|---|
5 | 3/2 | 6.18 ± 4.4 | 9.6 ± 2.6 | 100 ± 33.7 | 49.4 ± 11.8 | 47.6 ± 12.3 | 5.6 ± 0.5 | MTX (2) NSAID (4) |